|
FDA/Industry Meeting on Preclinical Assessment
of Reproductive Toxicity Data
Date: Thursday, June 24, 1999Time: 9 a.m. to 4 p.m.
Place: CDER Advisory Committee Conference Room 1066, 5630 Fishers Lane, Rockville, MD 20857
[Agenda and Paper]
FDA will hold a public meeting on June 24, 1999, to look at findings from studies of developmental and reproductive toxicity data and other information in order to render an integrative evaluation of the likelihood of human risk. The purpose of the meeting is to provide information on the agency's proposed approach, using several pharmaceutical data sets, and to invite members of the public to provide comments on the utility of the approach. This meeting is intended to provide feedback that could influence development of guidance for the purpose of assessing pharmaceutical reproductive risk evaluation. An agenda will be posted at this web site approximately two weeks prior to the meeting.
Registration Form (please type or print clearly)
Person Attending (name/title):_______________________________Company: _______________________________________________Phone number: ___________________________________________Fax number: _____________________________________________
E-mail address: ___________________________________________
Please R.S.V.P. by e-mail to wedge@cder.fda.gov. If e-mail is not available, registration may be faxed to the attention of Kimberly Topper, at (301) 827-6801 by June 11, 1999. Please note that registration is limited to the first 75 outside registrants, and is also limited within FDA. A picture ID will be needed to pick up your registration badge.
Last update: July 7, 2005 |
